¼¼°è AI °Ë¾È ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â ¸ÅÃâ ±âÁØÀ¸·Î 2023³â ¾à 1¾ï 2,695¸¸ ´Þ·¯¿¡¼ ¿¹Ãø ±â°£ µ¿¾È 82.55%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â¿¡´Â 89¾ï 7,898¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Áö¿ªº°·Î º¸¸é Áö³ ¸î ³â µ¿¾È ºÏ¹Ì¿Í ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀÌ Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ºÏ¹Ì ½ÃÀåÀÇ 2023³â ¸ÅÃâ Á¡À¯À²Àº 35.09%À̸ç, 2030³â¿¡´Â 20.15%°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀÇ ÆǸŠÁ¡À¯À²Àº 2023³â 47.98%¿¡¼ 2030³â¿¡´Â 67.44%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Á¦Ç° À¯Çü ¹× ±â¼ú Ãø¸é¿¡¼ ´ç´¢¸Á¸·º´Áõ(DR), ¿¬·É°ü·Ã Ȳ¹Ýº¯¼º(AMD), ±Ù½Ã, ±âŸ·Î ±¸ºÐµÇ¸ç, 2023³â¿¡´Â DRÀÌ 52.56%·Î °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2030³â¿¡´Â 57.88%¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
Á¦Ç° ¿ëµµ¿¡ µû¶ó ÀÇ·á ±â°ü°ú Great Health SceneÀ¸·Î ³ª´¹´Ï´Ù. ÀÇ·á±â°üÀÌ 2023³â 61.55%·Î °¡Àå Å« Á¡À¯À²À» º¸ÀÌ°í 2030³â¿¡´Â 53.23%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è AI °Ë¾È ½Ã½ºÅÛ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå ¹× Á¦Ç° °³¿ä, °æÀï »óȲ, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢ ºÎ¹®º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °¡°Ý µ¿Çâ, ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¢Á¾ ¿µÇâ¿äÀÎ ºÐ¼®, ÁÖ¿ä ±â¾÷ ºÐ¼® µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇص帳´Ï´Ù.
¸ñÂ÷
Á¦1Àå º¸°í¼ °³¿ä
- Á¶»ç ¹üÀ§
- À¯Çüº° ½ÃÀå ºÐ¼®
- ¼ºÀå·ü : 2019³â vs 2023³â vs 2030³â
- ´ç´¢¸Á¸·º´Áõ(DR)
- ³ëÀÎȲ¹Ýº¯¼º(AMD)
- ±Ù½Ã
- ±âŸ
- ¿ëµµº° ½ÃÀå
- ¼ºÀå·ü : 2019³â vs 2023³â vs 2030³â
- ÀÇ·á±â°ü
- Great Health Scene
- °¡Á¤°ú Á¦ÇÑ
- Á¶»ç ¸ñÀû
- Á¶»ç ±â°£
Á¦2Àå ¼¼°èÀÇ ¼ºÀå µ¿Çâ
- ¼¼°èÀÇ AI °Ë¾È ½Ã½ºÅÛ ½ÃÀå Àü¸Á
- ¼¼°èÀÇ AI °Ë¾È ½Ã½ºÅÛ ¼ºÀå µ¿Çâ : Áö¿ªº°
- ¼¼°è ½ÃÀå ±Ô¸ð : Áö¿ªº° : 2019³â vs 2023³â vs 2030³â
- ½ÃÀå ±Ô¸ð ÃßÀÌ : Áö¿ªº°
- ½ÃÀå ±Ô¸ð ¿¹Ãø : Áö¿ªº°
- ½ÃÀå ¿ªÇÐ
- ¾÷°è µ¿Çâ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ÀÌÁ¡
- Âü¿© À庮
Á¦3Àå °æÀï »óȲ : ÁÖ¿ä ±â¾÷º°
- ¼¼°èÀÇ »óÀ§ ±â¾÷ : ¸ÅÃ⺰
- ½ÃÀå Á¡À¯À² : ±â¾÷ À¯Çüº°
- ¼¼°èÀÇ ÁÖ¿ä ±â¾÷ : ¸ÅÃ⺰ ¼øÀ§
- ½ÃÀå ÁýÁß·ü
- ¼¼°èÀÇ ÁÖ¿ä ±â¾÷ : º»»ç
- ¼¼°èÀÇ ÁÖ¿ä ±â¾÷ : ¼³¸³ÀÏ
Á¦4Àå AI °Ë¾È ½Ã½ºÅÛ ½ÃÀå ³»¿ª µ¥ÀÌÅÍ : À¯Çüº°
Á¦5Àå AI °Ë¾È ½Ã½ºÅÛ ½ÃÀå ³»¿ª µ¥ÀÌÅÍ : ¿ëµµº°
Á¦6Àå ºÏ¹Ì
Á¦7Àå À¯·´
Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç
Á¦9Àå ³²¹Ì
Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦11Àå ÁÖ¿ä ±â¾÷ °³¿ä
- Airdoc Technology
- Digital Diagnostics
- Eyenuk
- RetinaLyze System
- Optomed
- Sibionics Technology
- Aeye Health
- VUNO
- Medimaging Integrated Solution
- EyRIS(SELENA+)
- Vistel
- RETINA-AI Health
Á¦12Àå ¾Ö³Î¸®½ºÆ®¿¡ ÀÇÇÑ °ßÇØ¡¤°á·Ð
Á¦13Àå ºÎ·Ï
ksm 24.04.01
The global revenue of Artificial Intelligence Eye Screening System in 2023 will be approximately US$ 126.95 million, and is expected to reach US$ 8,978.98 million from 2030 to 2030, with a CAGR of 82.55% during the period from 2024 to 2030.
From a regional perspective, the North America and Asia-Pacific market has accounted for a large share of sales in the past few years. In 2023, the sales share of the North America market will be 35.09%, and it is expected to reach 20.15% in 2030. In 2023, the sales share of the Asia-Pacific market will be 47.98%, and it is expected to reach 67.44% in 2030.
From the perspective of product type and technology, it can be divided into Diabetic Retinopathy (DR), Age-Related Macular Degeneration (AMD), Myopia and Others. Diabetic Retinopathy (DR) will account for the largest share in 2023, accounting for 52.56%, and the share is expected to reach 57.88% in 2030.
From the perspective of product market application, it can be divided into Medical Institutions and Great Health Scene. Medical Institutions will account for the largest share in 2023, accounting for 61.55%, and the share is expected to reach 53.23% in 2030.
Currently, major global companies include Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), Vistel and RETINA-AI Health, etc.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Eye Screening System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Eye Screening System.
The Artificial Intelligence Eye Screening System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Eye Screening System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence Eye Screening System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Airdoc Technology
- Digital Diagnostics
- Eyenuk
- RetinaLyze System
- Optomed
- Sibionics Technology
- Aeye Health
- VUNO
- Medimaging Integrated Solution
- EyRIS (SELENA+)
- Vistel
- RETINA-AI Health
Segment by Type
- Diabetic Retinopathy (DR)
- Age-Related Macular Degeneration (AMD)
- Myopia
- Others
Segment by Application
- Medical Institutions
- Great Health Scene
By Region
- North America
- USA
- Canada
- Mexico
- Asia-Pacific
- China
- Japan
- South Korea
- China Taiwan
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Rest of Europe
- South America
- Brazil
- Rest of South America
- Middle East & Africa
- Middle East
- Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, market drivers , advantages, entry barriers.
Chapter 3: Detailed analysis of Artificial Intelligence Eye Screening System company competitive landscape, revenue market share, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, etc.
Chapter 12: The main points and conclusions of the report.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Artificial Intelligence Eye Screening System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
- 1.2.2 Diabetic Retinopathy (DR)
- 1.2.3 Age-Related Macular Degeneration (AMD)
- 1.2.4 Myopia
- 1.2.5 Others
- 1.3 Market by Application
- 1.3.1 Global Artificial Intelligence Eye Screening System Market Growth by Application: 2019 VS 2023 VS 2030
- 1.3.2 Medical Institutions
- 1.3.3 Great Health Scene
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Artificial Intelligence Eye Screening System Market Perspective (2019-2030)
- 2.2 Global Artificial Intelligence Eye Screening System Growth Trends by Region
- 2.2.1 Global Artificial Intelligence Eye Screening System Market Size by Region: 2019 VS 2023 VS 2030
- 2.2.2 Artificial Intelligence Eye Screening System Historic Market Size by Region (2019-2024)
- 2.2.3 Artificial Intelligence Eye Screening System Forecasted Market Size by Region (2025-2030)
- 2.3 Artificial Intelligence Eye Screening System Market Dynamics
- 2.3.1 Artificial Intelligence Eye Screening System Industry Trends
- 2.3.2 Artificial Intelligence Eye Screening System Market Drivers
- 2.3.3 Advantages of Artificial Intelligence Eye Screening System
- 2.3.4 Artificial Intelligence Eye Screening System Industry Entry Barriers
3 Competition Landscape by Key Players
- 3.1 Global Top Artificial Intelligence Eye Screening System Players by Revenue
- 3.1.1 Global Top Artificial Intelligence Eye Screening System Players by Revenue (2019-2024)
- 3.1.2 Global Artificial Intelligence Eye Screening System Revenue Market Share by Players (2019-2024)
- 3.2 Global Artificial Intelligence Eye Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Global Key Players Ranking by Artificial Intelligence Eye Screening System Revenue
- 3.4 Global Artificial Intelligence Eye Screening System Market Concentration Ratio
- 3.4.1 Global Artificial Intelligence Eye Screening System Market Concentration Ratio (CR5)
- 3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Eye Screening System Revenue in 2023
- 3.5 Global Key Players of Artificial Intelligence Eye Screening System Headquarters
- 3.6 Global Key Players of Artificial Intelligence Eye Screening System Establish Date
4 Artificial Intelligence Eye Screening System Breakdown Data by Type
- 4.1 Global Artificial Intelligence Eye Screening System Historic Market Size by Type (2019-2024)
- 4.2 Global Artificial Intelligence Eye Screening System Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence Eye Screening System Breakdown Data by Application
- 5.1 Global Artificial Intelligence Eye Screening System Historic Market Size by Application (2019-2024)
- 5.2 Global Artificial Intelligence Eye Screening System Forecasted Market Size by Application (2025-2030)
6 North America
- 6.1 North America Artificial Intelligence Eye Screening System Market Size (2019-2030)
- 6.2 North America Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 6.3 North America Artificial Intelligence Eye Screening System Market Size by Country (2019-2024)
- 6.4 North America Artificial Intelligence Eye Screening System Market Size by Country (2025-2030)
- 6.5 United States
- 6.6 Canada
- 6.7 Mexico
7 Europe
- 7.1 Europe Artificial Intelligence Eye Screening System Market Size (2019-2030)
- 7.2 Europe Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 Europe Artificial Intelligence Eye Screening System Market Size by Country (2019-2024)
- 7.4 Europe Artificial Intelligence Eye Screening System Market Size by Country (2025-2030)
- 7.5 Germany
- 7.6 France
- 7.7 U.K.
- 7.8 Italy
- 7.9 Russia
8 Asia-Pacific
- 8.1 Asia-Pacific Artificial Intelligence Eye Screening System Market Size (2019-2030)
- 8.2 Asia-Pacific Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Asia-Pacific Artificial Intelligence Eye Screening System Market Size by Region (2019-2024)
- 8.4 Asia-Pacific Artificial Intelligence Eye Screening System Market Size by Region (2025-2030)
- 8.5 China
- 8.6 Japan
- 8.7 India
- 8.8 Australia
- 8.9 China Taiwan
- 8.10 South Korea
9 South America
- 9.1 South America Artificial Intelligence Eye Screening System Market Size (2019-2030)
- 9.2 South America Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 South America Artificial Intelligence Eye Screening System Market Size by Country (2019-2024)
- 9.4 South America Artificial Intelligence Eye Screening System Market Size by Country (2025-2030)
- 9.5 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Artificial Intelligence Eye Screening System Market Size (2019-2030)
- 10.2 Middle East & Africa Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Middle East & Africa Artificial Intelligence Eye Screening System Market Size by Country (2019-2024)
- 10.4 Middle East & Africa Artificial Intelligence Eye Screening System Market Size by Country (2025-2030)
- 10.5 Middle East
- 10.6 Africa
11 Key Players Profiles
- 11.1 Airdoc Technology
- 11.1.1 Airdoc Technology Company Details
- 11.1.2 Airdoc Technology Business Overview
- 11.1.3 Airdoc Technology Artificial Intelligence Eye Screening System Introduction
- 11.1.4 Airdoc Technology Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.2 Digital Diagnostics
- 11.2.1 Digital Diagnostics Company Details
- 11.2.2 Digital Diagnostics Business Overview
- 11.2.3 Digital Diagnostics Artificial Intelligence Eye Screening System Introduction
- 11.2.4 Digital Diagnostics Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.3 Eyenuk
- 11.3.1 Eyenuk Company Details
- 11.3.2 Eyenuk Business Overview
- 11.3.3 Eyenuk Artificial Intelligence Eye Screening System Introduction
- 11.3.4 Eyenuk Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.4 RetinaLyze System
- 11.4.1 RetinaLyze System Company Details
- 11.4.2 RetinaLyze System Business Overview
- 11.4.3 RetinaLyze System Artificial Intelligence Eye Screening System Introduction
- 11.4.4 RetinaLyze System Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.5 Optomed
- 11.5.1 Optomed Company Details
- 11.5.2 Optomed Business Overview
- 11.5.3 Optomed Artificial Intelligence Eye Screening System Introduction
- 11.5.4 Optomed Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.6 Sibionics Technology
- 11.6.1 Sibionics Technology Company Details
- 11.6.2 Sibionics Technology Business Overview
- 11.6.3 Sibionics Technology Artificial Intelligence Eye Screening System Introduction
- 11.6.4 Sibionics Technology Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.7 Aeye Health
- 11.7.1 Aeye Health Company Details
- 11.7.2 Aeye Health Business Overview
- 11.7.3 Aeye Health Artificial Intelligence Eye Screening System Introduction
- 11.7.4 Aeye Health Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.8 VUNO
- 11.8.1 VUNO Company Details
- 11.8.2 VUNO Business Overview
- 11.8.3 VUNO Artificial Intelligence Eye Screening System Introduction
- 11.8.4 VUNO Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.9 Medimaging Integrated Solution
- 11.9.1 Medimaging Integrated Solution Company Details
- 11.9.2 Medimaging Integrated Solution Business Overview
- 11.9.3 Medimaging Integrated Solution Artificial Intelligence Eye Screening System Introduction
- 11.9.4 Medimaging Integrated Solution Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.10 EyRIS (SELENA+)
- 11.10.1 EyRIS (SELENA+) Company Details
- 11.10.2 EyRIS (SELENA+) Business Overview
- 11.10.3 EyRIS (SELENA+) Artificial Intelligence Eye Screening System Introduction
- 11.10.4 EyRIS (SELENA+) Revenue in Artificial Intelligence Eye Screening System Business (2020-2024)
- 11.11 Vistel
- 11.11.1 Vistel Company Details
- 11.11.2 Vistel Business Overview
- 11.11.3 Vistel Artificial Intelligence Eye Screening System Introduction
- 11.11.4 Vistel Revenue in Artificial Intelligence Eye Screening System Business (2019-2024)
- 11.12 RETINA-AI Health
- 11.12.1 RETINA-AI Health Company Details
- 11.12.2 RETINA-AI Health Business Overview
- 11.12.3 RETINA-AI Health Artificial Intelligence Eye Screening System Introduction
- 11.12.4 RETINA-AI Health Revenue in Artificial Intelligence Eye Screening System Business (2022-2024)
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer